ENDOMETRIAL CANCER
Clinical trials for ENDOMETRIAL CANCER explained in plain language.
Never miss a new study
Get alerted when new ENDOMETRIAL CANCER trials appear
Sign up with your email to follow new studies for ENDOMETRIAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Weight-Loss drug may slow uterine tumors before surgery
Disease control Not yet recruitingThis study tests whether tirzepatide, a drug used for diabetes and weight loss, can slow or stop the growth of early-stage endometrial cancer or its precursor (EIN) in women with obesity. Forty participants will either receive tirzepatide or standard care for 4 weeks before their…
Matched conditions: ENDOMETRIAL CANCER
Phase: PHASE2 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated Apr 28, 2026 23:51 UTC
-
New drug combo aims to shrink advanced cancers in early trial
Disease control Not yet recruitingThis study tests a new drug called QLS5132 combined with other cancer treatments for people with advanced solid tumors, including stomach, lung, endometrial, and ovarian cancers. The goal is to find safe doses and see if the combination can shrink tumors. About 626 participants w…
Matched conditions: ENDOMETRIAL CANCER
Phase: PHASE1, PHASE2 • Sponsor: Qilu Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Apr 28, 2026 23:49 UTC